The “Liquid Biopsy Market” report has been added to Research and Markets’ offering.
The liquid biopsy market is expected to grow at near double digit annual growth rate. Abilities of liquid biopsy such as minimal invasiveness, possibility of continuous monitory of patient’s response towards treatment, and monitory of clonal mutations, combined with growing prominence for precision medicine have fueled the growth of liquid biopsy market.
The research study comprises of in-depth analysis of market trends and market size through different approaches. The entire market has been segmented and estimated in five different approaches namely by product & services, by biomarker and technology, by cancer type, by end users, and by geography.
In terms of by products & services the market has been segmented into kits & reagents, platforms & instruments, and services. In terms of by biomarker and technology the market has been segmented into circulating tumor cell (CTC), circulating tumor DNA (ctDNA), and extracellular vesicles (EV).
In terms of by cancer type the market has been segmented into lung cancer, breast cancer, colorectal cancer, prostate cancer, and liver cancer. In terms of by end users the market has been tracked through hospital & laboratory, government & academic research centers.
Key Topics Covered:
1 Executive Summary
2 Report Scope And Methodology
3 Market Dynamics
4 Liquid Biopsy Market, By Product & Service
5 Liquid Biopsy Market, By Circulating Biomarker Using Different Technologies Such As Ngs And Pcr Microarrays
6 Liquid Biopsy Market, By Cancer Type
7 Liquid Biopsy Market, By End User
8 Competitive Landscape
9 Liquid Biopsy Market, By Geography
10 Company Profiles
– ANGLE plc
– Adaptive Biotechnologies
– Bio-Rad Laboratories Inc.
– Biocept Inc.
– CareDx
– Cynvenio Biosystems, Inc.
– Epic Sciences
– F.Hoffmann-La Roche AG
– Genomic Health
– Guardant Health, Inc.
– Illumina, Inc.
– JOHNSON& JOHNSON
– MDxHealth, Inc.
– Menarini Silicon Biosystems, Inc.
– Myriad Genetics, Inc.
– Natera, Inc.
– NeoGenomics Laboratories, Inc.
– QIAGEN
– RainDance Technologies, Inc.
– Sysmex Corporation
– Thermo Fisher Scientific
– Trovagene Inc.
For more information about this report visit https://www.researchandmarkets.com/research/ltx5sx/liquid_biopsy